Fauci sees US decision to resume J & J vaccine by Friday

Credit: PIXTA / CC0 public domain

The decision to end the US suspension of vaccination with Johnson & Johnson’s COVID-19 shots is likely to be made by Friday, said Anthony Fauci, a top US pandemic adviser. Said on Sunday.

A government-convened expert committee has assessed the potential link between coagulopathy and vaccines in half a dozen younger women, and no woman has ever been known to have a coagulopathy.

Meanwhile, the European Medicines Agency said on Friday that it expects to determine the safety of Johnson & Johnson’s shots on Tuesday after evaluating data on blood clotting.

“I need an answer about where I’m going, and I don’t think I’ll extend this beyond Friday,” Fauci said in an interview with ABC “this week.” Pause. “

Coagulopathy is a “very rare event,” he said, noting that he didn’t want to be ahead of the expert panel convened by the US Centers for Disease Control and Prevention (CDC).

“We believe it will come back,” he said, but there were probably some restrictions and warnings about its use.

Vulnerable group

U.S. health officials have reported six women who developed a stroke with a decrease in platelet count, including one death, within two weeks of receiving a single vaccination. All women were between the ages of 18 and 49.

Shots were given to about 7.2 million Americans.

Some experts oppose continuing the suspension and fear that a single-dose vaccine that can be stored in the refrigerator can disproportionately affect vulnerable groups that are accessible.

However, most people felt that further research was needed given the abundance of other vaccines in the United States that do not have the same safety concerns given the very serious nature of blood clots. It was.

CDC director Rochelle Walensky states that the symptoms of women with coagulation disorders are consistent with the rare side effects of the AstraZeneca vaccine found in Europe.

Some European officials have hinted that the European Union may not order AstraZeneca shots again after asking about side effects and delays in their delivery.

Both the J & J vaccine and the AstraZeneca vaccine are based on adenovirus vector technology, similar to Sputnik V in Russia and CanSino in China.

The problem of coagulation has nothing to do with the Pfizer or Moderna vaccine.

US officials have emphasized that by the end of July they had ordered the supply of sufficient amounts of Moderna and Pfizer vaccines to cover the adult population.

Although the United States has become a world leader in vaccination, Forch said the United States remains in an “unstable position” and too many people ignore health precautions.

“There are an average of over 60,000 new infections a day in seven days, which is where you don’t want to be,” he said.

About 30 million people are vaccinated each week in the United States.

But Fauci warned, “We also need to pay attention to the wind and not prematurely declare victory. It’s not the time to do so.”

Follow the latest news about the outbreak of coronavirus (COVID-19)

© 2021 AFP

Quote: Fauci decides that the United States will resume the J & J vaccine by Friday (April 18, 2021), April 18, 2021 I think it was obtained from -jj-vaccine.html.

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.

Fauci sees US decision to resume J & J vaccine by Friday

Source link Fauci sees US decision to resume J & J vaccine by Friday

Show More

Related Articles

Back to top button